|
1
|
Pfirrmann T, Villavicencio-Lorini P,
Subudhi AK, Menssen R, Wolf DH and Hollemann T: RMND5 from Xenopus
laevis is an E3 ubiquitin-ligase and functions in early embryonic
forebrain development. PLoS One. 10:e01203422015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maitland MER, Onea G, Chiasson CA, Wang X,
Ma J, Moor SE, Barber KR, Lajoie GA, Shaw GS and Schild-Poulter C:
The mammalian CTLH complex is an E3 ubiquitin ligase that targets
its subunit muskelin for degradation. Sci Rep. 9:98642019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Wijk SJ, de Vries SJ, Kemmeren P,
Huang A, Boelens R, Bonvin AM and Timmers HT: A comprehensive
framework of E2-RING E3 interactions of the human
ubiquitin-proteasome system. Mol Syst Biol. 5:2952009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McTavish CJ, Berube-Janzen W, Wang X,
Maitland MER, Salemi LM, Hess DA and Schild-Poulter C: Regulation
of c-Raf Stability through the CTLH Complex. Int J Mol Sci.
20:9342019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huffman N, Palmieri D and Coppola V: The
CTLH complex in cancer cell plasticity. J Oncol. 2019:42167502019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li J, Chen Y, Qin X, Wen J, Ding H, Xia W,
Li S, Su X, Wang W, Li H, et al: miR-138 downregulates miRNA
processing in HeLa cells by targeting RMND5A and decreasing
Exportin-5 stability. Nucleic Acids Res. 42:458–474. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu H and Ye H: Screening of the
prognostic targets for breast cancer based co-expression modules
analysis. Mol Med Rep. 16:4038–4044. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Djuranovic S, Nahvi A and Green R: A
parsimonious model for gene regulation by miRNAs. Science.
331:550–553. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kusenda B, Mraz M, Mayer J and Pospisilova
S: MicroRNA biogenesis, functionality and cancer relevance. Biomed
Pap Med Fac Univ Palacky Olomouc Czech Repub. 150:205–215. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brennecke J, Hipfner DR, Stark A, Russell
RB and Cohen SM: Bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the
proapoptotic gene hid in Drosophila. Cell. 113:25–36. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang JT, Wang F, Chapin W and Huang RS:
Identification of MicroRNAs as breast cancer prognosis markers
through the cancer genome atlas. PLoS One. 11:e01682842016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu K, Zhang Z, Zhang H, Wang Z and Wang
F: miR-142-3p targeting NUCKS1 inhibits proliferation and invasion
of pancreatic cancer cells. Artif Cells Nanomed Biotechnol.
48:415–424. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamauchi A, Yamamura M, Katase N, Itadani
M, Okada N, Kobiki K, Nakamura M, Yamaguchi Y and Kuribayashi F:
Evaluation of pancreatic cancer cell migration with multiple
parameters in vitro by using an optical real-time cell mobility
assay device. BMC Cancer. 17:2342017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roussos ET, Condeelis JS and Patsialou A:
Chemotaxis in cancer. Nat Rev Cancer. 11:573–587. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lambert AW, Pattabiraman DR and Weinberg
RA: Emerging biological principles of metastasis. Cell.
168:670–691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu BB, Gu ZF, Ma M, Wang JY and Wang HN:
MicroRNA-590-5p suppresses the proliferation and invasion of
non-small cell lung cancer by regulating GAB1. Eur Rev Med
Pharmacol Sci. 22:5954–5963. 2018.PubMed/NCBI
|
|
24
|
Xu Y, Han T, Zhu Y and Chen Q: miR-590-5P
inhibits the progression of tongue squamous cell carcinoma by
targeting FasL. Int J Clin Exp Pathol. 10:11880–11887.
2017.PubMed/NCBI
|
|
25
|
Yan M, Ye L, Feng X, Shi R, Sun Z, Li Z
and Liu T: MicroRNA-590-3p inhibits invasion and metastasis in
triple-negative breast cancer by targeting Slug. Am J Cancer Res.
10:965–974. 2020.PubMed/NCBI
|
|
26
|
Gao J, Yu SR, Yuan Y, Zhang LL, Lu JW,
Feng JF and Hu SN: MicroRNA-590-5p functions as a tumor suppressor
in breast cancer conferring inhibitory effects on cell migration,
invasion, and epithelial-mesenchymal transition by downregulating
the Wnt-β-catenin signaling pathway. J Cell Physiol. 234:1827–1841.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shan X, Miao Y, Fan R, Qian H, Chen P, Liu
H, Yan X, Li J and Zhou F: miR-590-5P inhibits growth of HepG2
cells via decrease of S100A10 expression and Inhibition of the Wnt
pathway. Int J Mol Sci. 14:8556–8569. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen M, Wu L, Tu J, Zhao Z, Fan X, Mao J,
Weng Q, Wu X, Huang L, Xu M and Ji J: miR-590-5p suppresses
hepatocellular carcinoma chemoresistance by targeting YAP1
expression. EBioMedicine. 35:142–154. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mou K, Liu B, Ding M, Mu X, Han D, Zhou Y
and Wang LJ: lncRNA-ATB functions as a competing endogenous RNA to
promote YAP1 by sponging miR-590-5p in malignant melanoma. Int J
Oncol. 53:1094–1104. 2018.PubMed/NCBI
|
|
30
|
Chu Y, Ouyang Y, Wang F, Zheng A, Bai L,
Han L, Chen Y and Wang H: MicroRNA-590 promotes cervical cancer
cell growth and invasion by targeting CHL1. J Cell Biochem.
115:847–853. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xiao X, Tang C, Xiao S, Fu C and Yu P:
Enhancement of proliferation and invasion by MicroRNA-590-5p via
targeting PBRM1 in clear cell renal carcinoma cells. Oncol Res.
20:537–544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang L, Wei WQ, Wu ZY and Wang GC:
MicroRNA-590-5p regulates cell viability, apoptosis, migration and
invasion of renal cell carcinoma cell lines through targeting
ARHGAP24. Mol Biosyst. 13:2564–2573. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu M, Zhou X, Zhang J and Zhang Y:
MicroRNA-590-5p promotes cell survival in endometrioid endometrial
cancer by suppressing tumor suppressor PTEN. Int J Clin Exp Pathol.
10:7836–7846. 2017.PubMed/NCBI
|
|
34
|
Jiang X, Xiang G, Wang Y, Zhang L, Yang X,
Cao L, Peng H, Xue P and Chen D: MicroRNA-590-5p regulates
proliferation and invasion in human hepatocellular carcinoma cells
by targeting TGF-β RII. Mol Cells. 33:545–551. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang X and Wu X: miRNA expression profile
of vulvar squamous cell carcinoma and identification of the
oncogenic role of miR-590-5p. Oncol Rep. 35:398–408. 2016.
View Article : Google Scholar : PubMed/NCBI
|
